Cargando…
Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients
Autores principales: | Greenwood, Helene, Thippu Jayaprakash, Kamalram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829685/ http://dx.doi.org/10.1016/S0169-5002(22)00068-X |
Ejemplares similares
-
Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021) -
Characteristics of Inpatients with False-Negative SARS-CoV-2 PCR Test Results
por: Kraft, Antigone, et al.
Publicado: (2021) -
Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022) -
Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic?
por: Ni Chleirigh, Romy, et al.
Publicado: (2021) -
In Vitro Evaluation of Notch Inhibition to Enhance Efficacy of Radiation Therapy in Melanoma
por: Thippu Jayaprakash, Kamalram, et al.
Publicado: (2020)